Johnson & Johnson (NYSE: JNJ) is Today’s Stock Spotlight

Johnson & Johnson (NYSE: JNJ) is the focus on IBN’s latest stock spotlight. The company’s shares have moved 0.37% on the day to $151.80.

Johnson & Johnson researches and develops, manufactures, and sells various products in the healthcare field worldwide. It operates in three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; and acetaminophen products under the TYLENOL brand.

So far today, approximately 3.91M shares of Johnson & Johnson have been exchanged, as compared to an average 30-day volume of 8.29M shares.

Johnson & Johnson share prices have moved between a 52-week high of $181.77 and a 52-week low of $151.23. The stock has moved -1.8% over the past week.

Mentions of Johnson & Johnson on Twitter have totaled 400 in the past 24 hours, as compared to 430 in the prior 24 hours (a change of -6.98%). On Stocktwits, posts totaled 32 for the same period, as compared to 53 in the prior 24 hours (a change of -39.62%).

To learn more about Johnson & Johnson, visit the company’s website at

Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts

To stay connected with our complimentary IBN Spotlights, please visit

About IBN

IBN consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through our Dynamic Brand Portfolio (DBP), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.